RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
60 results for "Psyche" — page 1 of 3
X_2_03 — Psychedelic Medicine: Clinical Evidence and Renaissance
The psychedelic renaissance — the resurgence of clinical research into psychedelic compounds after decades of prohibition — represents one of the most significant paradigm shifts in modern psychiatry. Psilocybin for trea
K_3_17 — Psychedelic Consciousness — DMT, Psilocybin Neural Effects
The psychedelic renaissance in neuroscience — a period of renewed scientific investigation beginning circa 2006 after decades of regulatory restriction — has produced an unprecedented body of neuroimaging, pharmacologica
INTERDOC_20 — Psychedelic Neuroscience and Ancient Ritual Practice
[KEY FINDING] The Johns Hopkins Center for Psychedelic and Consciousness Research, the Imperial College Centre for Psychedelic Research (est. 2019, directed by Robin Carhart-Harris), and the MAPS (Multidisciplinary Assoc
Y_1_04 — Psychedelic Renaissance — Clinical Research and Consciousness
The psychedelic renaissance — a resurgence of rigorous scientific research on psychedelic substances after decades of prohibition — has produced some of the most significant findings in 21st-century psychiatry and consci
Y_1_06 — Psychedelic Research — Modern Science and Ancient Entheogen Parallels
Psychedelic research has undergone a dramatic revival since ~2006, with major studies at Johns Hopkins, Imperial College London, NYU, and MAPS demonstrating the therapeutic potential of psilocybin, MDMA, and ayahuasca/DM
Y_1_15 — Micro-Dosing: Sub-Perceptual Psychedelic Use and Cognitive Effects
Micro-dosing — the practice of regularly consuming sub-perceptual doses (typically 1/10th to 1/20th of a standard recreational dose) of psychedelic substances, most commonly LSD (~10–20 micrograms) or psilocybin (~0.1–0.
Y_1_07 — Ego Dissolution and Psychedelic Neuroscience
Ego dissolution — the temporary loss of the subjective sense of self, personal boundaries, and the distinction between self and world — is among the most profound and therapeutically significant effects of serotonergic p
Y_1_16 — Psychedelic Legal Frameworks: Regulation, Decriminalization, and Therapeutic Access
The legal status of psychedelic substances — including psilocybin, LSD, MDMA, DMT/ayahuasca, mescaline, and ibogaine — has undergone dramatic shifts since the mid-20th century, moving from unregulated research compounds
Y_1_01 — Altered States, Psychedelics & Ancient Knowledge
Psychoactive substances played a significant — possibly central — role in ancient knowledge traditions. The Eleusinian Mysteries (kykeon), Vedic tradition (Soma), Egyptian practice (blue lotus), and Mesoamerican religion
H_4_06 — Suppression of Psychedelic Research (1960s–2000s)
From the late 1940s through the mid-1960s, psychedelic substances — particularly LSD (lysergic acid diethylamide) and psilocybin — were the subject of extensive legitimate scientific research, with over 1,000 peer-review
ZE_3_06 — Ethics of Psychedelic Research and Therapy
The ethics of psychedelic research and therapy addresses the unique moral challenges posed by substances that profoundly alter consciousness in therapeutic, religious, and research contexts. After a 40-year research mora
X_5_26 — Psychedelic Medicine: The Johns Hopkins Center and the Therapeutic Renaissance
The psychedelic therapy renaissance — centered at the Johns Hopkins Center for Psychedelic and Consciousness Research (established 2019, originally launched as a research program in 2000) — represents one of the most sig
INTERDOC_72 — The Psychedelic Entropy Paradox: Coherence Through Anarchy
The "Entropic Brain" hypothesis, pioneered by Robin Carhart-Harris (Imperial College London), demonstrates that under the influence of classic psychedelics (psilocybin, LSD, DMT), the brain's Default Mode Network (DMN) d
Z_4_06 — Psychedelic Neurochemistry: 5-HT2A, Tryptamines, and Molecular Mechanisms
Psychedelic neurochemistry — the molecular-level study of how psychedelic compounds alter brain function to produce their characteristic effects (visual hallucinations, synesthesia, ego dissolution, mystical-type experie
Y_4_06 — Synesthesia and Cross-Modal Perception
Synesthesia — the involuntary, consistent experience of one sensory modality triggering perception in another (e.g., hearing colors, tasting shapes) — affects roughly 4% of the general population when broad subtype defin
Y_5_20 — MDMA Pharmacology: Entactogen Mechanisms, Therapeutic Potential, and Risks
MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy or molly, is a synthetic entactogen (from Latin tactus, "touching within") that produces profound feelings of emotional closeness, empathy, trust, and w
Y_3_13 — Visionary Art: Depicting Altered States from Hildegard to Grey
Visionary art — artistic creation inspired by, depicting, or emerging from altered states of consciousness — spans the entire history of human image-making, from Paleolithic cave paintings (whose geometric patterns David
Y_1_03 — Classical Antiquity Entheogens Synthesis
This document examines Classical Antiquity Entheogens Synthesis, a topic within the Consciousness research area. Key areas of investigation include Were Ancient Mediterranean Religions Entheogenic?, Why This Matters, The
Y_1_14 — Toad Venom: Bufo alvarius, 5-MeO-DMT, and Desert Sacrament
Toad venom — specifically the venom of the Sonoran Desert toad (Incilius alvarius, formerly Bufo alvarius) — contains 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), one of the most potent psychoactive tryptamines known, p
Y_1_10 — Ibogaine: African Plant Medicine and Addiction Interruption
Ibogaine is a naturally occurring psychoactive indole alkaloid derived from the root bark of the West African shrub Tabernanthe iboga, which has been used for centuries in the Bwiti spiritual tradition of Gabon, Cameroon
BROWSE BY SECTION — 3721 documents across 34 fields